Antiretroviral Therapy, Highly Active

Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies.

Publication Date: 
Nov 25, 2011

The success of potent antiretroviral treatment for HIV infection is primarily determined by adherence. We systematically review the evidence of effectiveness of interventions to increase adherence to antiretroviral treatment in sub-Saharan Africa.

Adherence counseling and reminder text messages improve uptake of antiretroviral therapy in a tertiary hospital in Nigeria.

Publication Date: 
Jun 17, 2013

CONTEXT: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is one of the world's most challenging pandemics. For treatment with Highly Active Anti-Retroviral Therapy (HAART) to be effective, high rate of adherence is essential.

The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol.

Journal Title: 
Publication Date: 
Oct 13, 2009

BACKGROUND: The objectives are to compare the effectiveness of cell phone-supported SMS messaging to standard care on adherence, quality of life, retention, and mortality in a population receiving antiretroviral therapy (ART) in Nairobi, Kenya.

Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial.

Publication Date: 
Nov 12, 2009

OBJECTIVE: To determine the relative efficacy of peer support and pager messaging strategies versus usual care to improve medication adherence and clinical outcomes among HIV-positive outpatients initiating or switching to a new highly active antiretroviral therapy regimen.

The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study.

Journal Title: 
Publication Date: 
Jun 22, 2006

Long-term medication regimen adherence is challenging in all populations, but in the HIV-infected adolescent population the frequency of poverty, homelessness, substance abuse, and mental illness make highly active antiretroviral therapy (HAART) adherence even more challenging.